Online Pharmacy Medicine Blog

Nicorrette has helped many smokers kick the habit. Revia (Naltrexone) has helped many alcoholics relieve their dependency. Sabril (vigabatrin) reduces cocaine cravings and has helped many kick the addiction.

What’s next, a drug to help users kick their Facebook addiction? Not likely…but, you never know.

The New York Times recently reported that many teens, the majority girls, are forming Facebook support groups to deal with their addiction.

“It’s like any other addiction,” psychologist Kimberly Young, the director of the Center for Internet Addiction Recovery in Bradford, Penn., told The Times. “Its hard to wean yourself.”

According to the article, one boy even said that “Facebook wasn’t merely a distraction, but it was really confusing him about who he was,” and he decided to spend his senior year away from the service. He was apparently burned out trying to live up to his own descriptions of himself.

Facebook also doesn’t let you quit so easily, teens that wish to give the axe to Facebook must check off six reasons why they want to quit. And if they have a weak moment and decide to reactivate their account, all they have to due is simply sign in with their original login and password information and pick up right where they left off.

The anticonvulsant Sabril (vigabatrin) was approved by the FDA last Friday for the treatment of epilepsy and infantile spasms. The drug was already available in Canada, the U.K., Denmark and Mexico.

You can buy and compare low cost prices on Sabril from trusted Canadian online pharmacies here.

The Los Angeles Times reports that Sabril is the first drug approved in the United States for infantile spasms, a terrible disease that can cause babies to have hundreds of spasms in a day.

The onset of infantile spasms usually occurs between the ages of four and eight months. The seizures are characterized by a sudden bending forward of the body and a stiffening of the arms and legs. U.S. doctors have used prednisone to treat the condition to date, with limited success.

Here’s video of a baby named Kailani having infantile spasms:

Although infantile spasms generally clear up by age 5, patients are prone to other forms of epilepsy later in life.

In addition to infantile spasms, Sabril is approved to treat epilepsy sufferers with so-called “complex partial seizures,” which affect about 1 million Americans.

As the Times points out, there are reasons the FDA took its time to OK Sabril:

The drug … is not perfect. As many as 30% of those who use it suffer from a loss of peripheral vision, although it does not affect central vision and such tasks as reading. Patients who use the drug will have to be monitored very closely for loss of vision…

The Times adds that many U.S. parents have been buying Sabril from Canadian pharmacies for years to treat infantile spasms.

Source